Methylation detection of the Septin 9 gene in circulating DNA in plasma, obtained from a peripheral blood sample, can be a useful, non-invasive, and effective method for screening for CRC in our environment. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.